← FDA Drug Approvals (Drugs@FDA)
ATAZANAVIR SULFATE;RITONAVIR;LAMIVUDINE;ZIDOVUDINE
NDA · New Drug Application · Sponsor: MYLAN LABS LTD · Approved 2014-09-04
Drug application
- FDA Application #
NDA206041- Application type
- New Drug Application
- Brand name
- ATAZANAVIR SULFATE;RITONAVIR;LAMIVUDINE;ZIDOVUDINE
- Generic name
- Atazanavir Sulfate
- Active ingredients
- ATAZANAVIR SULFATE; RITONAVIR; LAMIVUDINE; ZIDOVUDINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- MYLAN LABS LTD
- First approval
- 2014-09-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown